(Total Views: 201)
Posted On: 12/17/2019 4:14:58 PM
Post# of 281
NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Extension of Secured Promissory Note
Predictive Oncology (NASDAQ: POAI), a data and artificial intelligence (“AI”) driven discovery services company that provides predictive models of tumor drug response to improve clinical outcomes for patients, today announced the extension of its secured promissory note. According to the update, the note’s maturity date was extended from December 31, 2019 to March 31, 2020. In addition, the outstanding principal amount of the note was increased by $120,000 to a current principal amount of $2,029,104. Predictive Oncology issued 15,000 shares of common stock to the investor in connection with certain amended terms.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Predictive Oncology (NASDAQ: POAI), a data and artificial intelligence (“AI”) driven discovery services company that provides predictive models of tumor drug response to improve clinical outcomes for patients, today announced the extension of its secured promissory note. According to the update, the note’s maturity date was extended from December 31, 2019 to March 31, 2020. In addition, the outstanding principal amount of the note was increased by $120,000 to a current principal amount of $2,029,104. Predictive Oncology issued 15,000 shares of common stock to the investor in connection with certain amended terms.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)
